Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2024-07-03

Clinical Trial Update: Goal Attainment Scaling (GAS) Sub-Study

View source ↗

Summary

Update on a Goal Attainment Scaling (GAS) sub-study in a trial for Alzheimer's disease in Down syndrome; the study has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: LuMind IDSC Foundation | Conditions: Alzheimer's Disease in Down Syndrome | Status: COMPLETED